Ivette M. Essers
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Responsiveness of spondyloarthritis-specific health utilities based on the ASAS Health Index (U-ASAS-HI): an ancillary analysis from the ASAS-HI validation study.
Journal: Rheumatology (Oxford, England)
Published: April 04, 2025
Performance of spondyloarthritis-specific health utilities based on the ASAS Health Index: an ancillary analysis from the ASAS-HI validation study.
Journal: Rheumatology (Oxford, England)
Published: November 26, 2024
Barriers and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: A systematic literature review.
Journal: Seminars in arthritis and rheumatism
Published: May 07, 2024
Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.
Journal: Rheumatology (Oxford, England)
Published: April 16, 2019
'Ecstasy-light' - not as light as its name suggests: toxic effects of 4-fluoroamphetamine
Journal: Nederlands tijdschrift voor geneeskunde
Published: June 30, 2017
Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.
Journal: Arthritis care & research
Published: August 19, 2016
Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
Journal: Arthritis care & research
Published: February 26, 2016
Which aspects of health are most important for patients with spondyloarthritis? A Best Worst Scaling based on the ASAS Health Index.
Journal: Rheumatology (Oxford, England)
Published: November 02, 2015
Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis.
Journal: Rheumatology (Oxford, England)
Published: October 28, 2015
Last Updated: 09/26/2026